Stockscreener 앱 받기
6.82
1.49%
0.10
시간 외 거래:
6.97
0.15
+2.20%
전일 마감가:
$6.72
열려 있는:
$6.79
하루 거래량:
6,385
Relative Volume:
0.24
시가총액:
$10.40M
수익:
$24.50M
순이익/손실:
$-29.84M
주가수익비율:
-0.1909
EPS:
-35.7342
순현금흐름:
$-17.25M
1주 성능:
+2.71%
1개월 성능:
+9.29%
6개월 성능:
+0.97%
1년 성능:
-67.15%
1일 변동 폭
$6.50
$6.97
1주일 범위
$6.13
$7.57
52주 변동 폭
$4.14
$23.04
Lifeward Ltd Stock (LFWD) Company Profile
명칭
Lifeward Ltd
전화
15082511154
주소
200 DONALD LYNCH BLVD., MARLBOROUGH
Compare LFWD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
6.82 | 10.24M | 24.50M | -29.84M | -17.25M | -35.73 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-10 | 개시 | Laidlaw | Buy |
| 2017-04-03 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2016-12-16 | 개시 | Oppenheimer | Outperform |
| 2016-07-15 | 개시 | Piper Jaffray | Overweight |
| 2015-05-22 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2015-05-08 | 재확인 | Barclays | Equal Weight |
| 2014-10-07 | 개시 | Barclays | Equal Weight |
모두보기
Lifeward Ltd 주식(LFWD)의 최신 뉴스
LFWD Stock: HC Wainwright & Co. Raises Price Target to $10.00 | - GuruFocus
Lifeward stock price target raised to $10 on partnership strength By Investing.com - Investing.com Canada
Risk Report: Will Lifeward Ltd stock hit new highs in YEARPortfolio Update Summary & High Return Trade Guides - baoquankhu1.vn
Lifeward stock price target raised to $10 on partnership strength - Investing.com UK
Lifeward reports net loss of USD 5.3M in Q4 2025 - Medical Buyer
Lifeward shares fall after Q4 results miss expectations - MSN
Lifeward Shares Rise 5.1% on Expanded Distribution Deal in UAE and GCC - MSN
Lifeward Ltd (LFWD) Q4 2025 Earnings Call Highlights: Strategic Moves and Market Challenges - GuruFocus
Lifeward Ltd. Announces Strategic Expansion, Acquisition of Exoskeleton Technology, and Improved 2025 Financial Results - Minichart
Lifeward Ltd’s 2025 Earnings Call: Revenue Miss, Medicare Pipeline Discrepancies, and Timelines Clash - Bitget
Lifeward 2025 10-K: Revenue $22.0M, Gross Profit $8.4M - TradingView
Lifeward (LFWD) expands neurorehab platform with Oramed deal and Medicare gains - Stock Titan
Lifeward (LFWD) Pursues Growth with New Strategic Partnership - GuruFocus
Lifeward (LFWD) 2025 Financials: Q4 Revenue $5.1M, Annual Loss $19.9MNews and Statistics - IndexBox
Lifeward: Overview of Fourth Quarter Financial Results - Bitget
Lifeward Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Lifeward Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
LFWD: 2025 revenue fell 14%, but ReWalk unit sales rose 22% and gross margin improved - TradingView
Earnings call transcript: Lifeward Q4 2025 earnings reveal significant shortfall - Investing.com
Lifeward posts Q4 revenue $5.1M, FY2025 revenue $22.0M; net loss narrows to $19.9M - TradingView
LFWD: Strategic shift and new partnerships drive innovation, efficiency, and expanded market access - TradingView
Lifeward: Q4 Earnings Snapshot - KVUE
Oramed deal reshapes Lifeward (NASDAQ: LFWD) with new tech and funding - Stock Titan
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Press Release: Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results - 富途牛牛
Geopolitics Watch: Is Lifeward Ltd forming bullish engulfing patterns2026 Market WrapUp & AI Powered Market Trend Analysis - baoquankhu1.vn
Lifeward Ltd (LFWD) Q4 2025: Everything You Need To Know Ahead O - GuruFocus
Short Covering: Can Lifeward Ltd maintain sales growth2026 Intraday Action & Weekly Sector Rotation Insights - baoquankhu1.vn
Lifeward regains Nasdaq minimum bid price compliance By Investing.com - Investing.com Nigeria
Lifeward Shareholders Approve Oratech Deal and Governance Changes - The Globe and Mail
Lifeward shareholders approve Oramed partnership deal By Investing.com - Investing.com India
LFWD SEC FilingsLifeward Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Lifeward shareholders approve Oratech acquisition and board changes By Investing.com - Investing.com South Africa
Lifeward shareholders approve Oratech acquisition and board changes - Investing.com Nigeria
Lifeward shareholders approve Oramed partnership deal - Investing.com
Lifeward (NASDAQ: LFWD) holders approve Oratech deal share issuance - Stock Titan
Shareholders back Lifeward–Oramed bet on insulin pills and $47M war chest - Stock Titan
LFWD Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed-Creating Diversified Biomedical Company - Bitget
Lifeward regains compliance with Nasdaq - Medical Buyer
Lifeward Ltd. Regains Nasdaq Compliance by Meeting Minimum Bid Price Requirement - Minichart
Lifeward regains Nasdaq compliance with minimum bid price rule By Investing.com - Investing.com Canada
Lifeward Regains Compliance With Nasdaq Minimum Bid Rule - TipRanks
Lifeward regains Nasdaq compliance with minimum bid price rule - Investing.com
Lifeward regains Nasdaq $1.00 minimum bid compliance after 10-day run - TradingView
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement - The Manila Times
Lifeward (NASDAQ: LFWD) restores Nasdaq minimum bid price compliance and closes deficiency - Stock Titan
Lifeward regains Nasdaq minimum bid price compliance - Investing.com
Lifeward Regains Compliance With Nasdaq Minimum Bid Price Requirement - 富途牛牛
Lifeward Ltd (LFWD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):